FindTrial
Sign In

Effects of Stigmasterol Supplementation on Gut Microbiota and Its Metabolic Network Mechanisms in Female Obesity

Effects of Stigmasterol Supplementation on Gut Microbiota and Its Metabolic Network Mechanisms in Female Obesity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000989
Enrollment
Unknown
Registered
2026-04-16
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight/Obesity

Interventions

Placebo Group:Corn Starch
Low-Dose Stigmasterol Group:Stigmasterol 1 g/day
Medium-Dose Stigmasterol Group:Stigmasterol 2 g/day
High-Dose Stigmasterol Group:Stigmasterol 5 g/day

Sponsors

Obstetrics & Gynecology Hospital of Fudan University, Yangtze River Delta Integration Demonstration Zone (QingPu)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: BMI = 24 kg/m², aged between 20 and 55 years old; No pregnancy, cancer, hepatitis, hormone use or medication taking; Good compliance and willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: BMI 55 years old; Pregnancy, cancer, hepatitis, hormone use or medication taking.

Design outcomes

Primary

MeasureTime frame
Triglyceride;cholesterol;Low-density lipoprotein cholesterol;Metabolomics Indicators;Metagenomic Sequencing Indicators;—

Secondary

MeasureTime frame
High-density lipoprotein cholesterol;—

Countries

China

Contacts

Public ContactGuo panpan

Obstetrics & Gynecology Hospital of Fudan University, Yangtze River Delta Integration Demonstration Zone (QingPu)

guopanpan2016@163.com16628556306

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026